Last10K.com

Krystal Biotech, Inc. (KRYS) SEC Filing 8-K Material Event for the period ending Wednesday, April 29, 2020

Krystal Biotech, Inc.

CIK: 1711279 Ticker: KRYS

View differences made from one to another to evaluate Krystal Biotech, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Krystal Biotech, Inc..

Continue

Assess how Krystal Biotech, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Krystal Biotech, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: KRYS
CIK: 1711279
Form Type: 8-K Corporate News
Accession Number: 0001193125-20-133769
Submitted to the SEC: Tue May 05 2020 4:28:05 PM EST
Accepted by the SEC: Tue May 05 2020
Period: Wednesday, April 29, 2020
Industry: Biological Products No Disgnostic Substances
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/krys/0001193125-20-133769.htm